Enable job alerts via email!
A biotech company in Montreal is seeking a Cell Therapy Supply Chain Logistics Associate to oversee the patient journey through CAR-T therapies. The candidate will manage logistics functions and support clinical operations, ensuring timely and efficient treatment delivery. Ideal candidates will have a relevant degree and experience in the biotech or pharma sectors.
Cell Therapy Supply Chain Logistics Associate – Nexcella, Inc. Montreal / Hybrid
Overseeing the patient journey from screening through treatment across CAR-T therapies. You will work cross-functionally with internal and external stakeholders to ensure therapies reach patients as quickly and efficiently as possible.
Nexcella, Inc. is a subsidiary of Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases. Our lead candidate is sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201 with a “digital filter” that filters out non-specific activation. NXC-201 is being evaluated in the U.S. multi-center study for relapsed/refractory AL Amyloidosis NEXICART-2 (NCT06097832), with a registrational design. Interim results were presented at ASCO 2025 in an oral presentation by Heather Landau, M.D. of Memorial Sloan Kettering Cancer Center. NXC-201 has been awarded Regenerative Medicine Advanced Therapy (RMAT) by the US FDA and Orphan Drug Designation (ODD) by FDA and in the EU by the EMA. Learn more at www.nexcella.com and www.BeProactiveInAL.com.